Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9485376rdf:typepubmed:Citationlld:pubmed
pubmed-article:9485376lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9485376lifeskim:mentionsumls-concept:C0086661lld:lifeskim
pubmed-article:9485376lifeskim:mentionsumls-concept:C0033713lld:lifeskim
pubmed-article:9485376lifeskim:mentionsumls-concept:C2243187lld:lifeskim
pubmed-article:9485376pubmed:issue8lld:pubmed
pubmed-article:9485376pubmed:dateCreated1998-3-20lld:pubmed
pubmed-article:9485376pubmed:abstractTextTriplex-forming oligonucleotides (TFOs) have been shown to inhibit both transcription in vitro and the expression of target genes in cell culture by binding to polypurine/polypyrimidine sequences in several human gene promoters. The c-myc protooncogene is overexpressed in a variety of human cancers and appears to play an important role in the proliferation of these cells. In an attempt to assay the ability of triplex-forming oligonucleotides to inhibit expression of a target gene in vivo, we have developed a cellular system involving transfection of a c-myc promoter-driven luciferase reporter plasmid with triplex-forming oligonucleotides targeted to the human c-myc protooncogene. To increase the stability of the TFO, we have used modified phosphorothioate oligonucleotides. Triplex formation with a modified phosphorothioate oligonucleotide occurs with approximately equal binding affinity as that seen using a phosphodiester oligonucleotide. Phosphorothioate-modified TFOs targeted to c-myc inhibit transcription of the c-myc promoter in HeLa cells as demonstrated by a decrease in luciferase expression from a luciferase reporter gene construct. These results suggests that triplex formation may represent a gene-specific means of inhibiting specific protooncogene expression.lld:pubmed
pubmed-article:9485376pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9485376pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9485376pubmed:languageenglld:pubmed
pubmed-article:9485376pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9485376pubmed:citationSubsetIMlld:pubmed
pubmed-article:9485376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9485376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9485376pubmed:statusMEDLINElld:pubmed
pubmed-article:9485376pubmed:monthFeblld:pubmed
pubmed-article:9485376pubmed:issn0006-2960lld:pubmed
pubmed-article:9485376pubmed:authorpubmed-author:MillerD MDMlld:pubmed
pubmed-article:9485376pubmed:authorpubmed-author:ThomasSSlld:pubmed
pubmed-article:9485376pubmed:authorpubmed-author:LamK MKMlld:pubmed
pubmed-article:9485376pubmed:authorpubmed-author:MayfieldCClld:pubmed
pubmed-article:9485376pubmed:authorpubmed-author:VigneswaranNNlld:pubmed
pubmed-article:9485376pubmed:authorpubmed-author:EbbinghausSSlld:pubmed
pubmed-article:9485376pubmed:authorpubmed-author:JonesD EDEJrlld:pubmed
pubmed-article:9485376pubmed:authorpubmed-author:ReddochJ FJFlld:pubmed
pubmed-article:9485376pubmed:issnTypePrintlld:pubmed
pubmed-article:9485376pubmed:day24lld:pubmed
pubmed-article:9485376pubmed:volume37lld:pubmed
pubmed-article:9485376pubmed:ownerNLMlld:pubmed
pubmed-article:9485376pubmed:authorsCompleteYlld:pubmed
pubmed-article:9485376pubmed:pagination2299-304lld:pubmed
pubmed-article:9485376pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:meshHeadingpubmed-meshheading:9485376-...lld:pubmed
pubmed-article:9485376pubmed:year1998lld:pubmed
pubmed-article:9485376pubmed:articleTitleInhibition of transcription of the human c-myc protooncogene by intermolecular triplex.lld:pubmed
pubmed-article:9485376pubmed:affiliationDepartment of Biochemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294-0001, USA.lld:pubmed
pubmed-article:9485376pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9485376pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9485376pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:9485376pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9485376lld:pubmed